Bots, editor, reviewer, Administrators
13,941
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 517: | Line 517: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2018-07-11T03:22:16Z", | ||
"briefDesignDescription" : "Andexanet for reversing Xa inhibitors", | "briefDesignDescription" : "Andexanet for reversing Xa inhibitors", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1510991", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1510991", | ||
| Line 536: | Line 536: | ||
}, | }, | ||
{ | { | ||
"timestamp" : "2018- | "timestamp" : "2018-07-11T03:30:14Z", | ||
"briefDesignDescription" : "Andexanet for reversing Xa inhibitors", | "briefDesignDescription" : "Andexanet for reversing Xa inhibitors", | ||
"fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1607887", | "fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1607887", | ||
| Line 542: | Line 542: | ||
"pdfurl" : null, | "pdfurl" : null, | ||
"trainingLevel" : "Resident", | "trainingLevel" : "Resident", | ||
"citation" : "Connolly SJ, <i>et al</i>. \"Andexanet | "citation" : "Connolly SJ, <i>et al</i>. \"Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors\". <i>The New England Journal of Medicine</i>. 2016. 375(12):1131-1141.", | ||
"subspecialties" : "Hematology", | "subspecialties" : "Hematology", | ||
"expansion" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors", | "expansion" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors", | ||
| Line 551: | Line 551: | ||
"diseases" : "Hemorrhage", | "diseases" : "Hemorrhage", | ||
"abbreviation" : "ANNEXA-4", | "abbreviation" : "ANNEXA-4", | ||
"title" : "Andexanet | "title" : "Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors", | ||
"pmid" : "27573206" | "pmid" : "27573206" | ||
}, | }, | ||